TY - JOUR
T1 - Developing an Instrument to Assess the Readiness for Advance Care Planning
AU - Sakai, Shima
AU - Nagae, Hiroko
AU - Miyashita, Mitsunori
AU - Harasawa, Nozomi
AU - Iwasaki, Takako
AU - Katayama, Yoko
AU - Takenouchi, Sayaka
AU - Ikeda, Mari
AU - Ito, Mari
AU - Tamura, Keiko
N1 - Funding Information:
This study was supported by JSPS KAKENHI Grant Number 15H02586 Grant-in-Aid for Scientific Research (A) and 15K20782 Grant-in-Aid for Young Scientists (B).
Publisher Copyright:
© 2021 American Academy of Hospice and Palliative Medicine
PY - 2022/3
Y1 - 2022/3
N2 - Context: In recent times, advance care planning for patients’ end-of-life care preferences has attracted much attention worldwide. Objectives: To develop the Readiness for Advance Care Planning (RACP) Scale. Methods: Participants included 624 Japanese citizens who were registered with a web-based survey company as of February 2019. Items regarding the process of advance care planning (ACP) were developed based on a literature review and expert panel discussions. The expert panel included nine experts and practitioners in the field of end-of-life care. Construct validity, concurrent validity, internal consistency, and test-retest reliability were evaluated. Results: Initially, 37 items were collected. Examination of the floor effect, item-total, good–poor analysis, and exploratory factor analysis yielded a five-factor model with 28 items. The goodness of fit of the model was GFI = 0.80, CFI = 0.91, and RMSEA = 0.08. The concurrent validity was statistically significant (rs = 0.26–0.45, ps < 0.001). Cronbach's alpha for the overall scale was 0.95. The corresponding values for the subscales ranged from 0.90 to 0.97. The intraclass correlation coefficients indicating test-retest reliability was 0.66 (P < 0.001) for the total scale and ranged from 0.52–0.65 for the five subscales. Conclusions: The validity and reliability of the scale were generally acceptable. The RACP is an appropriate instrument to evaluate the level of readiness for ACP behaviors among people of various generations at every health stage. More studies are needed to examine the clinical utility of the RACP, both nationally and internationally.
AB - Context: In recent times, advance care planning for patients’ end-of-life care preferences has attracted much attention worldwide. Objectives: To develop the Readiness for Advance Care Planning (RACP) Scale. Methods: Participants included 624 Japanese citizens who were registered with a web-based survey company as of February 2019. Items regarding the process of advance care planning (ACP) were developed based on a literature review and expert panel discussions. The expert panel included nine experts and practitioners in the field of end-of-life care. Construct validity, concurrent validity, internal consistency, and test-retest reliability were evaluated. Results: Initially, 37 items were collected. Examination of the floor effect, item-total, good–poor analysis, and exploratory factor analysis yielded a five-factor model with 28 items. The goodness of fit of the model was GFI = 0.80, CFI = 0.91, and RMSEA = 0.08. The concurrent validity was statistically significant (rs = 0.26–0.45, ps < 0.001). Cronbach's alpha for the overall scale was 0.95. The corresponding values for the subscales ranged from 0.90 to 0.97. The intraclass correlation coefficients indicating test-retest reliability was 0.66 (P < 0.001) for the total scale and ranged from 0.52–0.65 for the five subscales. Conclusions: The validity and reliability of the scale were generally acceptable. The RACP is an appropriate instrument to evaluate the level of readiness for ACP behaviors among people of various generations at every health stage. More studies are needed to examine the clinical utility of the RACP, both nationally and internationally.
KW - Readiness for Advance Care Planning Scale
KW - advance care planning
KW - reliability
KW - validity
UR - http://www.scopus.com/inward/record.url?scp=85123001855&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85123001855&partnerID=8YFLogxK
U2 - 10.1016/j.jpainsymman.2021.10.009
DO - 10.1016/j.jpainsymman.2021.10.009
M3 - Article
C2 - 34756955
AN - SCOPUS:85123001855
SN - 0885-3924
VL - 63
SP - 374
EP - 386
JO - Journal of Pain and Symptom Management
JF - Journal of Pain and Symptom Management
IS - 3
ER -